Difference between revisions of "Team:Lethbridge"

 
(23 intermediate revisions by 3 users not shown)
Line 5: Line 5:
 
{{Template:Lethbridge/mini-template-css}}
 
{{Template:Lethbridge/mini-template-css}}
 
<html>
 
<html>
 +
<style>
 +
.content a {color: darkslategray !important; text-decoration: underline !important}
 +
</style>
 
<body><br><br>
 
<body><br><br>
 
<img src="https://static.igem.org/mediawiki/2018/c/ca/T--Lethbridge--banner_MainPage1.png" width=100% alt="Main Page Banner">
 
<img src="https://static.igem.org/mediawiki/2018/c/ca/T--Lethbridge--banner_MainPage1.png" width=100% alt="Main Page Banner">
 
<div class="content"> <!--everything added for content goes after this line-->
 
<div class="content"> <!--everything added for content goes after this line-->
 
<br>
 
<br>
−
 
−
 
−
<div style="clear:both"></div><br>
 
−
 
−
<div class="content">
 
−
 
  
 
<center>
 
<center>
−
<video>
+
<video controls>
 
   <source src="https://static.igem.org/mediawiki/2018/0/02/T--Lethbridge--video_Vincent.mp4" type="video/mp4">
 
   <source src="https://static.igem.org/mediawiki/2018/0/02/T--Lethbridge--video_Vincent.mp4" type="video/mp4">
 
</video>
 
</video>
 
</center>
 
</center>
  
−
<center> <h1>Protein Nanocompartments</h1> </center>
+
<br><br>
  
−
<img src="https://static.igem.org/mediawiki/2018/e/e9/T--Lethbridge--vincentFace.png">
+
<center><h1>Protein Nanocompartments</h1></center>
  
−
<li class="f18">Modifiable surfaces for specific targeting and suitability of packaging for a variety of cargo types</li>
+
<div class="imageText-Wrapper">
 +
<div class="imageText-Image">
 +
<center><img src="https://static.igem.org/mediawiki/2018/e/e9/T--Lethbridge--vincentFace.png" width=55%></center>
 +
</div>
 +
<div class="imageText-Text">
 +
<p class="f12">VINCEnT is a standardized toolkit for simple design and assembly of custom protein nanocompartments (PNCs) for delivery of small molecules, nucleic acids, or proteins to specific cell targets. PNCs have user-specified surface proteins, encapsulation proteins, and cargo-loading approaches with wide-ranged applicability including targeted antibiotic delivery, rapid vaccine development, gene therapy, materials synthesis, improved cell culture transfection, specific biological control agents, and more. </p>
 +
</div>
 +
</div>
  
−
 
+
<div style="clear: both"></div><br>
−
<br>
+
  
 
<h1>Software</h1>
 
<h1>Software</h1>
  
−
<img src="https://static.igem.org/mediawiki/2018/6/60/T--Lethbridge--computer_vincent.png">
+
<div class="textImage-Wrapper">
 +
<div class="textImage-Text">
 +
<p class="f12">To enhance the accessibility of this toolkit, we designed a basic software tool that enables users to design a novel PNC to their own specifications based on suggested parts for their intended application. Standardized protocols accompany the pre-designed toolkit parts and, together with the simplified design, less experienced users are able to safely conduct complex experiments in a basic laboratory environment.</p>
 +
</div>
 +
<div class="textImage-Image">
 +
<center><img src="https://static.igem.org/mediawiki/2018/6/60/T--Lethbridge--computer_vincent.png" width: 60%></center>
 +
</div>
 +
</div>
  
−
<p class="f18">Software framework to begin database of PNCs </p>
+
<div style="clear: both"></div><br>
−
 
+
−
<br>
+
  
 
<h1>Risk Assessment Rubric</h1>
 
<h1>Risk Assessment Rubric</h1>
  
−
<img src="https://static.igem.org/mediawiki/2018/2/20/T--Lethbridge--law_vincent.png">
+
<div class="imageText-Wrapper">
 +
<div class="imageText-Image">
 +
<center><img src="https://static.igem.org/mediawiki/2018/9/9d/T--Lethbridge--vincentLaw1.png"></center>
 +
</div>
 +
<div class="imageText-Text">
 +
<p class="f12">A risk assessment rubric was developed for our toolkit with advice from PHAC (Public Health Agency of Canada) and members of ELBI (Emerging Leaders in Biosecurity Initiative).</p>
 +
</div>
 +
</div>
  
−
<p class="f18">Developed for our toolkit with advice from PHAC (Public Health Agency of Canada) and members of ELBI (Emerging Leaders in Biosecurity Initiative)</p>
+
<div style="clear: both"></div><br>
  
−
<br>
+
<h1>Cell-free Synthesis</h1>
 +
<div class="oneText-Wrapper">
 +
<div class="oneText-Text">
 +
<p class="f12"><b>Fifteen</b> parts were improved from our <a href="https://2017.igem.org/Team:Lethbridge" target="_blank">2017 N<i>ex</i>t <i>Vivo</i></a> project. Our goal was to continue standardizing, improving, and simplifying our protocols and we are now beginning design of cell-free PNC synthesis with these components.
 +
</p>
 +
</div>
 +
</div>
  
−
<h1>Cell-free Synthesis Components</h1>
+
<div style="clear: both"></div><br>
−
 
+
−
<li class="f18"> 15 parts improved from our N<i>ex</i>t <i>vivo</i> project. </li>
+
−
<li class="f18"> Our goal with these parts was to continue standardizing, improving and simplifying our protocols.</li>
+
−
<li class="f18"> Beginning design of Cell Free PNC Synthesis.</li>
+
  
 +
<div class="oneImage-Wrapper">
 +
<div class="oneImage-Image">
 
<img src="https://static.igem.org/mediawiki/2018/6/6e/T--Lethbridge--next_vivo.png">
 
<img src="https://static.igem.org/mediawiki/2018/6/6e/T--Lethbridge--next_vivo.png">
 +
</div>
 +
</div>
  
−
<br>
+
</div> <!-- closing out 'content'-->
−
 
+
−
 
+
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 02:36, 18 October 2018



Main Page Banner



Protein Nanocompartments

VINCEnT is a standardized toolkit for simple design and assembly of custom protein nanocompartments (PNCs) for delivery of small molecules, nucleic acids, or proteins to specific cell targets. PNCs have user-specified surface proteins, encapsulation proteins, and cargo-loading approaches with wide-ranged applicability including targeted antibiotic delivery, rapid vaccine development, gene therapy, materials synthesis, improved cell culture transfection, specific biological control agents, and more.


Software

To enhance the accessibility of this toolkit, we designed a basic software tool that enables users to design a novel PNC to their own specifications based on suggested parts for their intended application. Standardized protocols accompany the pre-designed toolkit parts and, together with the simplified design, less experienced users are able to safely conduct complex experiments in a basic laboratory environment.


Risk Assessment Rubric

A risk assessment rubric was developed for our toolkit with advice from PHAC (Public Health Agency of Canada) and members of ELBI (Emerging Leaders in Biosecurity Initiative).


Cell-free Synthesis

Fifteen parts were improved from our 2017 Next Vivo project. Our goal was to continue standardizing, improving, and simplifying our protocols and we are now beginning design of cell-free PNC synthesis with these components.